Posted inBiotechnology Tech-Driven Follow-Up Care for NICU Graduates April 20, 2026 In the delicate world of neonatal medicine, the journey of care does not end at discharge from the neonatal intensive…
Posted inBiotechnology JAK1 Inhibitors Fight Colitis via NLRP3 Blockade April 20, 2026 In a groundbreaking advance for the treatment of inflammatory bowel diseases, a recent study has illuminated the molecular intricacies through…
Posted inBiotechnology Heat-Loving Enzyme Revealed: A New Breakthrough to Enhance Plastic Recycling April 20, 2026 In the escalating global challenge of plastic pollution, innovative solutions are urgently needed to transform the way we manage and…
Posted inBiotechnology Self-Assembling Luminophores Create Nanotubes Enabling Multidirectional Exciton Transport April 20, 2026 In a groundbreaking advance at the intersection of supramolecular chemistry and optoelectronic materials science, a team of Japanese researchers has…
Posted inBiotechnology Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk April 20, 2026 In a groundbreaking exploration that promises to reshape the understanding of prenatal medication safety, researchers from the University of Nebraska…
Posted inBiotechnology Salmonella Haem Blocks Macrophages, Boosts Infection April 20, 2026 In a groundbreaking study that reshapes our understanding of bacterial immune evasion, scientists have identified a novel mechanism by which…
Posted inBiotechnology Zinc Ions Combat Iridovirus via Ferroptosis Control April 20, 2026 In a groundbreaking study that could revolutionize antiviral therapies, researchers have uncovered a remarkable mechanism by which zinc ions mitigate…
Posted inBiotechnology Lilly picks up another in vivo CAR-T company with Kelonia buyout worth up to $7B April 20, 2026 Eli Lilly is picking up its second in vivo CAR-T company of the year, paying $3.25 billion in upfront cash…
Posted inBiotechnology Biogen inks $850M biobucks deal with TJ Biopharma for China rights to late-stage immune antibody April 20, 2026 Following its move to secure ex-China rights to the CD38-directed antibody felzartamab, Biogen is doubling down and building on an…
Posted inBiotechnology Primary breast tumors contain cells with metastatic potential, new study reveals April 20, 2026 A groundbreaking study from the Cell Plasticity in Development and Disease laboratory, led by Ángela Nieto at the Institute for…